CSF-1R in Cancer: More than a Myeloid Cell Receptor.

CSF-1R cancer cell signaling cell migration cell proliferation chemoresistance stemness

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 Jan 2024
Historique:
received: 13 12 2023
revised: 04 01 2024
accepted: 05 01 2024
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Colony-stimulating factor 1 receptor (CFS-1R) is a myeloid receptor with a crucial role in monocyte survival and differentiation. Its overexpression is associated with aggressive tumors characterized by an immunosuppressive microenvironment and poor prognosis. CSF-1R ligands, IL-34 and M-CSF, are produced by many cells in the tumor microenvironment (TME), suggesting a key role for the receptor in the crosstalk between tumor, immune and stromal cells in the TME. Recently, CSF-1R expression was reported in the cell membrane of the cancer cells of different solid tumors, capturing the interest of various research groups interested in investigating the role of this receptor in non-myeloid cells. This review summarizes the current data available on the expression and activity of CSF-1R in different tumor types. Notably, CSF-1R

Identifiants

pubmed: 38254773
pii: cancers16020282
doi: 10.3390/cancers16020282
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Mesothelioma Applied Research Foundation
ID : MARF-ERK5
Organisme : Italian Association for Cancer Research
ID : IG-15378, IG-23179

Auteurs

Francesca Cersosimo (F)

Department of Biotechnology Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.

Silvia Lonardi (S)

Department of Molecular and Translational Medicine, University of Brescia, 25100 Brescia, Italy.

Cristina Ulivieri (C)

Department of Life Sciences, University of Siena, 53100 Siena, Italy.

Paolo Martini (P)

Department of Molecular and Translational Medicine, University of Brescia, 25100 Brescia, Italy.

Andrea Morrione (A)

Center for Biotechnology, Department of Biology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.

William Vermi (W)

Department of Molecular and Translational Medicine, University of Brescia, 25100 Brescia, Italy.

Antonio Giordano (A)

Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy.

Emanuele Giurisato (E)

Department of Biotechnology Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.

Classifications MeSH